Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Newer Targets
Hepion Pharmaceuticals’ CRV431 Prevents Cirrhosis in Experimental Model of Severe Liver…
Newer Targets
Palleon Pharmaceuticals to Present Preclinical Data on EAGLE-Her2 and Anti-Siglec-9 Antibody…
Newer Targets
Codiak Presents First Preclinical Data for exoASO, Engineered Exosomes Designed to…
Newer Targets
Nkarta Therapeutics Presents Preclinical Data for CD19 CAR NK Program
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Approval
AstraZeneca’s Calquence Wins FDA Approval for Chronic Lymphocytic Leukemia
Phase III
First China-manufactured Trastuzumab Biosimilar HLX02 Global Phase III Trial Met Primary…
Phase II
Abivax Receives French Regulatory Authority (ANSM) Approval to Include French Study…
Approval
BRUKINSA (zanubrutinib) Approved for the Treatment of Mantle Cell Lymphoma, Available…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Deals
AbbVie and Harpoon Expand Partnership with $510 Million Licensing Deal
Acquisitions
Appili Therapeutics Acquires Clinical Stage Antifungal Program From FUJIFILM Toyama Chemical
Deals
Astellas and Welldoc Enter into Strategic Alliance for Digital Therapeutics
Commercial
Eli Lilly to Add 100 Employees Following $400 Million Manufacturing Investment
Home
Therapy areas
Dermatology
Dermatology
Cardio-metabolism
Dermatology
Gastroenterology
Genitourinary
Haematology
Immuno-inflammation
Immuno-oncology
Infectious diseases
Musculoskeletal
Neurology
Nutritional Supplements
Ophthalmology
Orphan-paediatric
Others
Psychiatry
Respiratory
Vaccine
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Dermatology
XBiotech Announces Rapid Enrollment for its Randomized Multi-Center Clinical Study for Bermekimab in Patients with Hidradenitis Suppurativa
Biospace News
-
November 19, 2019
Dermatology
Lilly Presents Positive Results for Taltz (ixekizumab) in Pediatric Patients with Moderate to Severe Plaque Psoriasis at the 28th Annual European Academy of Dermatology...
Firstwordpharma News
-
October 13, 2019
Dermatology
Pfizer Presents Positive Phase 3 Data at the 28th Congress of...
Firstwordpharma News
-
October 13, 2019
0
Dermatology
Galderma Advances Phase 3 Clinical Study with Nemolizumab in Moderate-to-Severe Atopic...
Biospace News
-
October 10, 2019
0
Dermatology
Abeona Therapeutics Announces Presentation of EB-101 Data at Society for Investigative...
Firstwordpharma News
-
May 8, 2019
0
Dermatology
Abeona Therapeutics Announces Presentation of EB-101 Data at Society for Investigative...
Firstwordpharma News
-
May 8, 2019
0
Dermatology
Endo Announces Publication Of Collagenase Clostridium Histolyticum (CCH) Phase 2 Data...
Biospace News
-
March 19, 2019
0
1
2
3
Page 1 of 3
- Advertisement -
LATEST NEWS
CRISPR Therapeutics and Vertex: Promising Gene Therapy Data for Sickle Cell Disease and Beta Thalassemia
Biospace News
-
November 19, 2019
0
Boehringer Ingelheim and Optimum Patient Care Launch First US Primary Care Patient Registry to Improve COPD Care
May 21, 2019
Breakthrough cancer research by NZ-China project gets $5m boost ...
June 13, 2019
MUST READ
I-Mab Biopharma and MorphoSys Announce IND Clearance to Initiate Clinical Trials of TJ202/MOR202 for...
Biospace News
-
October 14, 2019
0
Debiopharm Expands its Immuno-Oncology Development Program for Debio 1143, with the First IAP Inhibitor/Nivolumab...
Biospace News
-
May 21, 2019
0
Chipscreen Biosciences Announces a Collaboration with Innovent to Evaluate Chidamide and the Combination of...
Biospace News
-
February 18, 2019
0
Load more
